Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Promising results for ferumoxytol in anemia and chronic kidney disease

Nov. 27, 2003

Britannia and US WorldMeds sign licensing agreement for lofexidine

Nov. 21, 2003

Novel 5-HT and/or dopamine receptor ligands discovered by Sepracor team

Nov. 19, 2003

Antalarmin reduces volitional ethanol consumption in rats

Nov. 18, 2003

Neramexane shows promise for the treatment of alcohol dependence

Nov. 18, 2003

TA-CD advances into phase IIb for cocaine addiction

Oct. 28, 2003

TA-NIC enters second phase I trial

Oct. 10, 2003

Potential benefits reported for the anticonvulsant vigabatrin in cocaine addiction

Oct. 7, 2003

SSR-591813, a partial alpha4beta2 nAChR agonist, effective in animal models of nicotine dependence

Aug. 29, 2003

New phase II trial evaluates NicVAX in smokers

Aug. 7, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Feb. 28, 2025
Roche looks to grow with sequencing by expansion tech
BioWorld MedTech
Roche Holding AG revealed plans to launch its sequencing by expansion technology next year, raising the possibility that rival Illumina Inc. could face a real run...
Clots and metastasis in cancer patients start in the lung
BioWorld MedTech
The lung and thrombosis may play a key role in cancer and metastasis progression, according to a collaborative study led by Cornell University scientists. In the...
Evo 2 AI allows genome and epigenome modeling of all life domains
BioWorld MedTech
A new version of Evo, the AI developed at the Arc Institute that can be used to design genomes as long as that of a bacterium, has been retrained with the DNA...